I020 Stock Overview
IMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
IMAC Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.09 |
| 52 Week High | US$9.36 |
| 52 Week Low | US$2.15 |
| Beta | 0.11 |
| 1 Month Change | 0% |
| 3 Month Change | 24.10% |
| 1 Year Change | -62.68% |
| 3 Year Change | -88.23% |
| 5 Year Change | n/a |
| Change since IPO | -97.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| I020 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 3.1% | -1.0% |
| 1Y | -62.7% | 2.1% | 2.0% |
Return vs Industry: I020 underperformed the German Healthcare industry which returned 10.6% over the past year.
Return vs Market: I020 underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| I020 volatility | |
|---|---|
| I020 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: I020 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine I020's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 85 | Jeff Ervin | www.imacholdings.com |
IMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company’s outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy.
IMAC Holdings, Inc. Fundamentals Summary
| I020 fundamental statistics | |
|---|---|
| Market cap | €2.00m |
| Earnings (TTM) | -€13.88m |
| Revenue (TTM) | €7.85m |
0.3x
P/S Ratio-0.1x
P/E RatioIs I020 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| I020 income statement (TTM) | |
|---|---|
| Revenue | US$8.47m |
| Cost of Revenue | US$8.78m |
| Gross Profit | -US$305.49k |
| Other Expenses | US$14.68m |
| Earnings | -US$14.99m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -13.17 |
| Gross Margin | -3.60% |
| Net Profit Margin | -176.86% |
| Debt/Equity Ratio | 4.3% |
How did I020 perform over the long term?
See historical performance and comparison